First Databank is First Clinical Decision Support Provider to Receive NICE Accreditation

First DatabankFirst Databank (FDB) has become the first drug knowledge base and clinical decision support provider to be awarded accreditation by NICE's Accreditation Programme. The NICE Accreditation Advisory Committee made its decision based on the process used to develop the clinical and medicines' information and the editorial rigour implemented across FDB's drug knowledge database, which underpins its products Multilex and FIRSTLight.

The accreditation process ensures a thorough and transparent evaluation, including technical analysis, peer review and consideration by an advisory committee of guidance experts. The pilot application included further review by Dr Maureen Baker, clinical director of patient safety at NHS Connecting for Health, and a team of safety engineers.

In a time when the public sector is charged with making significant efficiency improvements and achieving challenging NHS reforms, NICE’s role in providing recommendations to organisations in the public and private sector is of critical importance. This accreditation helps health and social care professionals identify the most robustly produced clinical decision support available, driving up the quality of care delivery. FDB is the only drug knowledge provider that has been given accreditation.

The accreditation assessment reviewed the processes that FDB uses to develop the clinical decision support content within its products, Multilex and FIRSTLight. The Multilex drug terminology holds clinical and commercial information on more than 75,000 pharmaceutical products and packs, and both products provide active clinical decision support and referential medicines information for all healthcare professionals, as well as endorsing and reimbursement support for community pharmacists and dispensing doctors.

NICE's accreditation of FDB's processes to develop the content in its clinical decision support, in parallel with the Connecting for Health assessment of the technology and the recommendations delivered in specific clinical settings, provides NHS organisations with reassurance of the overall quality of the clinical decision support system they are purchasing.

Darren Nichols, managing director of First Databank explains further; "FDB has led the way in having independent validation by NICE of the processes used in our drug knowledge and clinical decision support that forms the core of our product offering to the UK and International healthcare markets. The quality of our knowledge base, provided by our expert clinicians, researchers and health informaticists, means that Healthcare IT system vendors, and clinicians using our drug data within those systems, can have complete confidence in the clinical decision support we offer."

The NICE accreditation lasts for five years from the date of award.

Related news articles:

About First DataBank
First DataBank is the UK's leading provider of drug knowledge bases and active clinical decision support. With over 30 years' experience of maintaining, developing and integrating drug knowledge bases across the entire healthcare spectrum, First DataBank has unrivalled expertise and knowledge in this specialist field. NHS Connecting for Health has chosen First DataBank to provide drug-related clinical decision support.

Patient safety is the driving force behind our business. Through the effective integration of our products into clinical systems, we enable safer prescribing, dispensing and administration.

Our Multilex Drug Data File - the UK's most comprehensive and widely used drug knowledge base - is in daily use by thousands of healthcare professionals in the UK.

For further information visit www.firstdatabank.co.uk.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

Free AI Tools can Help Doctors Read Medi…

A new study from the University of Colorado Anschutz Medical Campus shows that free, open-source artificial intelligence (AI) tools can help doctors report medical scans just as well as more...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Autonomous AI Agents in Healthcare

The use of large language models (LLMs) and other forms of generative AI (GenAI) in healthcare has surged in recent years, and many of these technologies are already applied in...

Can Amazon Alexa or Google Home Help Det…

Computer scientists at the University of Rochester have developed an AI-powered, speech-based screening tool that can help people assess whether they are showing signs of Parkinson’s disease, the fastest growing...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...